CD19 and mantle cell lymphoma: Co-culture of 42105-74bbz CAR-T cells with the primary MCL patient cells (n = 5) at E:T ratio of 5:1 for 24 h resulted in significant lysis compared to UTT control in all the samples tested including one which relapsed after commercial CD19 CAR-T cell therapy (Fig. 4B).